Lawrence Corey

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Anne A Gershon

Professor

Columbia University Vagelos College of Physicians and Surgeons

UNITED STATES

View details

Sam Mbulaiteye

National Cancer Institute

UNITED STATES

View details

Herbert Virgin

Adjunct Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Maurine Miner

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Karen Kotloff

University of Maryland School of Medicine

UNITED STATES

View details

Laurie T. Krug

Stony Brook University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lawrence Corey

Research Interests

Explore related searches

Contact this professor

Articles (14)

Operation Warp Speed offers a roadmap for improving the efficiency of bench to bedside medical advances

Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up

Reflections on Progress in Genital Herpes Therapy and Prevention 1997 to 2024

The potential of broadly neutralizing antibodies for HIV prevention

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

Broadly neutralizing monoclonal antibodies for HIV prevention

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Behind the Scenes Heroes: The COVID-19 Vaccine Data and Safety Monitoring Board

After the pandemic: perspectives on the future trajectory of COVID-19

SARS-CoV-2 Variants in Patients with Immunosuppression

Collaborators (6)

Anne A Gershon

Sam Mbulaiteye

Herbert Virgin

Maurine Miner

Karen Kotloff

Laurie T. Krug

Make your next move.